tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Daniil Gataulin - 18 which are a Buy (75%), 6 which are a Hold (25%)
Analyst Daniil Gataulin works at CHARDAN CAPITAL and is covering the Healthcare sector with 42 price targets and ratings displayed on 8 stocks.
Daniil Gataulin's average stock forecast success ratio is 4.76% with an average time for price targets to be met of 34.71 days.
Most recent stock forecast was given on ADVM, Adverum Biotechnologies at 11-Aug-2023.
Analyst best performing recommendations are on ADVM (ADVERUM BIOTECHNOLOGIES).
The best stock recommendation documented was for ADVM (ADVERUM BIOTECHNOLOGIES) at 11/11/2022. The price target of $2 was fulfilled within 243 days with a profit of $1.23 (159.74%) receiving and performance score of 6.57.
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
3 months ago
3/3 (100%)
$-0.44 (-4.31%)
14
Hold
4
$2.5 (166.67%)
2
3 months 24 days ago
1/3 (33.33%)
$1.46 (113.82%)
243
Hold
6
1 years 24 days ago
1/3 (33.33%)
$4.34 (35.85%)
35
Hold
21
2 years 4 months 12 days ago
2/2 (100%)
$7.53 (88.83%)
197
Hold
3
$1.5 (100.00%)
17
2 years 4 months 12 days ago
1/2 (50%)
$2.74 (33.46%)
7
Which stock is Daniil Gataulin is most bullish on?
Which stock is Daniil Gataulin is most reserved on?
What Year was the first public recommendation made by Daniil Gataulin?
